tiprankstipranks
Moleculin Biotech (MBRX)
NASDAQ:MBRX

Moleculin Biotech (MBRX) Balance Sheet

1,327 Followers

Moleculin Biotech Balance Sheet

Moleculin Biotech's total assets for Q4 2023 were $38.22M, a decrease of -3.30% from the previous quarter. MBRX total liabilities were $12.14M for the fiscal quarter, a 176.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 38.22M$ 57.42M$ 84.09M$ 29.03M$ 25.23M
Total Liabilities
$ 12.14M$ 5.23M$ 5.14M$ 11.27M$ 9.66M
Total Equity Gross Minority
$ 26.08M$ 52.18M$ 78.95M$ 17.76M$ 15.57M
Total Capitalization
$ 26.55M$ 52.53M$ 78.95M$ 17.76M$ 15.57M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 277.00K$ 379.00K
Currency in USD

Moleculin Biotech Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis